ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

DeVita Swearing In Schedule Aug. 8

August 1, 1980

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005

Radiotherapy Plus Cetuximab May Control Head/Neck Cancer

November 26, 2010

DCT Advisors Approve Recompetition Of Drug Discovery Groups

June 23, 1995

NCI Advisory Group, Other Cancer Meetings

July 25, 1986